TransDigm Group Incorporated TDG reported second-quarter fiscal 2025 adjusted earnings of $9.11 per share, which beat the Zacks Consensus Estimate of $8.85 by 2.9%. The bottom line also improved 14% from the prior-year quarter’s figure of $7.99 per share. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) The company reported GAAP earnings of $8.24 per share compared with $6.97 in the year-ago quarter. The year-over-year growth in the bottom line can be attributed to the increase in net sales and the application of TDG’s value-driven operating strategy, lower one-time refinancing costs and decreased non-cash stock and deferred compensation expense. TransDigm’s Q2 Sales Discussion Sales amounted to $2.15 billion, up 12% from $1.92 billion registered in the prior-year period. The reported figure, however, missed the Zacks Consensus Estimate of $2.17 billion by 0.7%. Organic sales, as a percentage of net sales, grew 6.9%. Transdigm Group Incorporated Price, Consensus and EPS SurpriseTransdigm Group Incorporated Price, Consensus and EPS Surprise Transdigm Group Incorporated price-consensus-eps-surprise-chart | Transdigm Group Incorporated Quote TDG’s Operating Results The gross profit was $1.27 billion, up 10.6% from the year-ago quarter’s level of $1.15 billion. TDG’s interest expense increased 16% year over year to $378 million. Net income increased 18.9% year over year to $479 million. TransDigm’s Financial Position Cash and cash equivalents as of March 29, 2025, amounted to $2.43 billion, down from $6.26 billion recorded as of Sept. 30, 2024. Long-term debt totaled $24.31 billion, up from $24.30 billion as of Sept. 30, 2024. Cash from operating activities amounted to $900 million compared with $865 million at the end of the second quarter of fiscal 2024. TDG’s 2025 Guidance TransDigm reaffirmed its guidance for fiscal 2025. It still expects sales to be in the range of $8.75-$8.95 billion. The Zacks Consensus Estimate for the same is pegged at $8.86 billion, just above the midpoint of the company’s guided range. TDG still expects fiscal 2025 adjusted earnings to be in the band of $35.51-$37.43 per share. The Zacks Consensus Estimate for fiscal 2025 earnings is pegged at $37.09 per share, higher than the midpoint of the company’s guided range. TDG’s Zacks Rank TransDigm currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Recent Defense Releases Lockheed Martin Corporation LMT reported first-quarter 2025 earnings of $7.28 per share, which beat the Zacks Consensus Estimate of $6.34 by 14.8%. The bottom line increased 15% from the year-ago quarter's reported figure of $6.33 per share. The company’s net sales were $17.96 billion, which beat the consensus estimate of $17.76 billion by 1.1%. The top line also increased 4.5% from $17.20 billion reported in the year-ago quarter. Northrop Grumman Corporation NOC reported first-quarter 2025 adjusted earnings of $6.06 per share, which missed the Zacks Consensus Estimate of $6.21 by 2.4%. NOC’s total sales of $9.47 billion in the first quarter missed the consensus estimate of $9.91 billion by 4.4%. The top line also declined 6.6% from $10.13 billion reported in the year-ago quarter. RTX Corporation’s RTX first-quarter 2025 adjusted earnings per share of $1.47 beat the Zacks Consensus Estimate of $1.35 by 8.9%. The bottom line also improved 9.7% from the year-ago quarter’s level of $1.34 per share, driven by growth in adjusted segment operating profit. Its first-quarter sales totaled $20.31 billion, which surpassed the consensus estimate of $19.71 billion by 3%. The top line also surged a solid 5.2% from $19.31 billion recorded for the first quarter of 2024. Story Continues Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lockheed Martin Corporation (LMT):Free Stock Analysis Report Northrop Grumman Corporation (NOC):Free Stock Analysis Report Transdigm Group Incorporated (TDG):Free Stock Analysis Report RTX Corporation (RTX):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
TransDigm Q2 Earnings Surpass Estimates, Sales Increase Y/Y
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...